Louise Bicknell
Joined WhatDoTheyKnow in 2022
Send message to Louise Bicknell
Sign in to change password, subscriptions and more (Louise Bicknell only)
This person's Freedom of Information requests (approximately 84)
Communications request between the CMO and the Antivirals and Therapeutics Taskforce between 1 April and 6 September 2022
Response by Department of Health and Social Care to Louise Bicknell on .
Refused
Dear Ms Bicknell,
Your requested internal review of FOI-1499999 is now complete. Please see
the attached letter for the outcome.
Yours sincerely,...
Treatments for Highest Risk Non-Hospitalised Patients (Adults and Children) with COVID-19
Response by Medicines and Healthcare Products Regulatory Agency to Louise Bicknell on .
Successful
FOI 24/089
Dear Ms Bicknell,
Thank you for your request of 27 January 2024 under the Freedom of Information Act. You requested:
Please will you prov...
With ICO as the answer provided is directly contradicted by other documents provided by another authority
Communications between the Chief Medical Officer and the Scientific Advisory Group for Emergencies on the use of prophylaxis treatments including Evusheld
Response by NHS England to Louise Bicknell on .
Information not held
Freedom of Information Request Revised Response
Our Ref: FOI-2303-1934485
ICO Ref: IC-231102-T9M7
Dear Louise Bicknell,
We write further to your...
Shielded Persons, the Shielded Persons List and the use of Prophylaxis for COVID-19, UK CMOs meeting of July 2021
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Long overdue
Referred to the ICO as I do not consider these FOIAs vexatious, in fact DHSC has mischaracterised these to avoid answering these key questions
COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophylaxis National Expert Working Group meeting of 19 May 2022 attendees from the UKHSA and the Antivirals and Therapeutics Task Force
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
This is subject to internal review. DHSC has amalgamated this with the “Shielded persons, the shielded persons list and the use of prophylaxis for COV...
Revised process for the preparation of answers to Parliamentary Questions
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
This is subject to internal review. DHSC has amalgamated this with the “Shielded persons, the shielded persons list and the use of prophylaxis for COV...
Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
In respect of the redaction of names the ICO ruled that while there was a legitimate interest in disclosure they did not consider such disclosure was n...
Preparation of the COVID-19 Response: Living with COVID-19 by HMG and failing to address available prophylaxis treatments
Response by Department of Health and Social Care to Louise Bicknell on .
Partially successful
Dear Ms Bicknell,
Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1449046).
Your...
Preparation of Parliamentary answers on Evusheld
Response by Department of Health and Social Care to Louise Bicknell on .
Successful
Dear Ms Bicknell,
Your requested internal review of FOI-1442668 is now complete.
With apologies for the delay, please see the attached letter for t...
COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request
Response by NHS England to Louise Bicknell on .
Partially successful
Freedom of Information Internal Review outcome
Our Ref: FOI-2211-1870162
ICO Ref: IC-240304-T6P5
Dear Louise Bicknell,
We write further to your...
Provision of Paxlovid and Sotrovimab for those at higher risk from COVID-19
Request to NHS North West London Integrated Care Board by Louise Bicknell. Annotated by Louise Bicknell on .
Successful
Further to my earlier annotation. Reviewing the second link provided in answer to question 6, this is for health professionals and does contain the in...
Meetings of the Antivirals and Therapeutics Taskforce Engagement Board after 20 July 2022 to date
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
See response to FOIA Therapeutics Clinical Review Panel Meetings and minutes submitted on 13 February 2023 . DHSC provided this information on 12 July...
Therapeutics Clinical Review Panel meetings and minutes
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Successful
This is with the ICO for review
Attendees at the Expert Working Group on 19 May 2022
Response by NHS England to Louise Bicknell on .
Refused
Dear Louise Bicknell,
Thank you for your email of 12 June 2023 in which you requested
information under the FOI Act from NHS England.
Your request...
Meetings of the Prophylaxis Oversight Group from 1 June 2022 to date
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
After the involvement of the ICO the DHSC have now confirmed that there were no meetings within the timeframe
Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer
Awaiting internal review
ICO has confirmed that they are taking this (and the related cases) forward
Testing of Evusheld by UKHSA: inconsistency in information provided in a correction to written parliamentary answers and under my FOIA request
Response by UK Health Security Agency to Louise Bicknell on .
Partially successful
Dear Louise Bicknell,
Please find attached the UK Health Security Agency's response to your
request.
Yours sincerely,
Information Rights...
Review of CMDUs by the Antivirals and Therapeutics Task Force
Response by Department of Health and Social Care to Louise Bicknell on .
Partially successful
Dear Ms Bicknell,
Your requested internal review of FOI-1440905 is now complete. Please see
the attached letter for the outcome.
Yours sincerely,...
Communication and discussion of Evusheld testing results May 2022 onwards
Response by UK Health Security Agency to Louise Bicknell on .
Partially successful
Dear Louise Bicknell,
Please find attached the UK Health Security Agency's response to your
request.
Yours sincerely,
Information Rights...
Antibody Testing for COVID-19
Response by Department of Health and Social Care to Louise Bicknell on .
Partially successful
Dear Ms Bicknell,
Your requested internal review of FOI-1437593 is now complete. Please see
the attached letter for the outcome.
Once again, pleas...
Preparation of the COVID-19 Response: Living with COVID-19 by HMG in respect of prophylaxis treatments
Response by Department of Health and Social Care to Louise Bicknell on .
Refused
Dear Ms Bicknell,
Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1440831).
Your...
Changes to the shielding policy
Response by Department of Health and Social Care to Louise Bicknell on .
Successful
Dear Ms Bicknell,
Your requested internal review of FOI-1429069 is now complete. Please see
the attached letter for the outcome.
Yours sincerely,...
Testing of Sotrovimab/Xevudy
Response by UK Health Security Agency to Louise Bicknell on .
Partially successful
Dear Louise Bicknell,
Please find attached the UK Health Security Agency's response to your
request.
Yours sincerely,
Information Rights Team
P...
CMDU performance South East London follow up FOI 107092
Request to Guy's and St Thomas' NHS Foundation Trust by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
I view of the time elapsed and the answers being provided promptly by other CMDUs to these questions I decided not to follow up. A lesson for the futu...
This person's 55 annotations
With ICO as the answer provided is directly contradicted by other documents provided by another authority
Shielded Persons, the Shielded Persons List and the use of Prophylaxis for COVID-19, UK CMOs meeting of July 2021
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Long overdue
Referred to the ICO as I do not consider these FOIAs vexatious, in fact DHSC has mischaracterised these to avoid answering these key questions
COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophylaxis National Expert Working Group meeting of 19 May 2022 attendees from the UKHSA and the Antivirals and Therapeutics Task Force
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
This is subject to internal review. DHSC has amalgamated this with the “Shielded persons, the shielded persons list and the use of prophylaxis for COV...
Revised process for the preparation of answers to Parliamentary Questions
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
This is subject to internal review. DHSC has amalgamated this with the “Shielded persons, the shielded persons list and the use of prophylaxis for COV...
Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
In respect of the redaction of names the ICO ruled that while there was a legitimate interest in disclosure they did not consider such disclosure was n...
Communications between the Chief Medical Officer and the Scientific Advisory Group for Emergencies on the use of prophylaxis treatments including Evusheld
Information not held
Referred to ICO for failure to respond 3/9/23
Provision of Paxlovid and Sotrovimab for those at higher risk from COVID-19
Request to NHS North West London Integrated Care Board by Louise Bicknell. Annotated by Louise Bicknell on .
Successful
Further to my earlier annotation. Reviewing the second link provided in answer to question 6, this is for health professionals and does contain the in...
Provision of Paxlovid and Sotrovimab for those at higher risk from COVID-19
Request to NHS North West London Integrated Care Board by Louise Bicknell. Annotated by Louise Bicknell on .
Successful
While we have the answers, their webpage to which they refer does not contain any of the information, so people in this position and GPs (including min...
Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
With the ICO to review
Meetings of the Antivirals and Therapeutics Taskforce Engagement Board after 20 July 2022 to date
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
See response to FOIA Therapeutics Clinical Review Panel Meetings and minutes submitted on 13 February 2023 . DHSC provided this information on 12 July...
Therapeutics Clinical Review Panel meetings and minutes
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Successful
This is with the ICO for review
Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
Two are now answered. Three are still outstanding an answer. DHSC has said they are working on this and will revert as a priority
If no answer i wil...
Meetings of the Prophylaxis Oversight Group from 1 June 2022 to date
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
After the involvement of the ICO the DHSC have now confirmed that there were no meetings within the timeframe
Meetings of the Antivirals and Therapeutics Taskforce Engagement Board after 20 July 2022 to date
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Refused
After the involvement of the ICO the DHSC have confirmed on 30 June that there were no meetings after this date
Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer
Awaiting internal review
ICO has confirmed that they are taking this (and the related cases) forward
COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request
Partially successful
ICO advised to give 40 working days for NHSE to reply to internal review. This has now passed, so sent again to the ICO requesting that they follow up...
Communications mentioning Evusheld between Professor James Palmer and the Chief Medical Officer
Awaiting internal review
Referred to the ICO for failure to answer internal review request
COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request
Partially successful
Referred to ICO for failure to respond to request for internal review
Meeting of the Antivirals and Therapeutics Taskforce Strategy Board 19 January 2023
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
To be referred to the ICO
Therapeutics Clinical Review Panel meetings and minutes
Request to Department of Health and Social Care by Louise Bicknell. Annotated by Louise Bicknell on .
Successful
To be referred to the ICO
COVID-19 tixagevimab/cilgavimab (Evusheld) pre-exposure prophlyaxis National Expert Group minutes request
Partially successful
ICO issued decision notice on 6 February for failure to respond within the statutory time limit. Gave 35 working days to reply. Information still out...
CMDU performance South East London follow up FOI 107092
Request to Guy's and St Thomas' NHS Foundation Trust by Louise Bicknell. Annotated by Louise Bicknell on .
Partially successful
I view of the time elapsed and the answers being provided promptly by other CMDUs to these questions I decided not to follow up. A lesson for the futu...
Sajid Javid’s letter of 27 September 2021 changing the COVID shielding policy for the clinically extremely vulnerable
Request to Department of Health and Social Care by Penelope Crouch. Annotated by Louise Bicknell on .
Partially successful
Matter is with the ICO to determine as relevant information has been totally redacted and not provided on time
COVID-19 nMABs Access and Policy National Expert Group - Evusheld
Partially successful
ICO required a response. This was received on 8 February. As detailed above parts were missing. Requested internal review on 11 February 2023
COVID-19 nMABs Access and Policy National Expert Group - Evusheld
Partially successful
28/12/22
Sent to ICO for failure to respond to their response request